Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole
- PMID: 27549634
- PMCID: PMC5062774
- DOI: 10.4269/ajtmh.15-0860
Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole
Abstract
It is challenging to find safe, nonscarring and noninvasive treatment of facial cutaneous leishmaniasis (CL) in children. Herein, we report a child with CL from a region endemic for Leishmania tropica, whose lesion persisted after treatment with oral fluconazole but responded to topical paromomycin. Paromomycin should be considered early for treatment of Old World CL and is a well-tolerated and effective mode of therapy for facial lesions.
© The American Society of Tropical Medicine and Hygiene.
Figures
Similar articles
-
Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.Parasitol Res. 2007 May;100(6):1221-6. doi: 10.1007/s00436-006-0394-6. Epub 2007 Jan 6. Parasitol Res. 2007. PMID: 17206508
-
Treatment of Cutaneous Leishmaniasis in a Nonendemic Country: A Case Series of Children in Australia.Pediatr Infect Dis J. 2022 Apr 1;41(4):e177-e181. doi: 10.1097/INF.0000000000003445. Pediatr Infect Dis J. 2022. PMID: 34966136
-
Liposomal amphotericin B treatment of cutaneous leishmaniasis due to Leishmania tropica.J Eur Acad Dermatol Venereol. 2011 Aug;25(8):973-7. doi: 10.1111/j.1468-3083.2010.03908.x. Epub 2010 Dec 5. J Eur Acad Dermatol Venereol. 2011. PMID: 21129042 Clinical Trial.
-
Cutaneous leishmaniasis treatment.Travel Med Infect Dis. 2007 May;5(3):150-8. doi: 10.1016/j.tmaid.2006.09.004. Epub 2006 Oct 31. Travel Med Infect Dis. 2007. PMID: 17448941 Review.
-
[Management of cutaneous leishmaniasis in adults and children].Med Trop (Mars). 2005 Nov;65(5):487-95. Med Trop (Mars). 2005. PMID: 16465821 Review. French.
Cited by
-
A New Immunogenic Structure of Polyepitopic Fusion against Leishmania major: In Silico Study.Iran J Parasitol. 2024 Jul-Sep;19(3):290-304. doi: 10.18502/ijpa.v19i3.16387. Iran J Parasitol. 2024. PMID: 39318820 Free PMC article.
References
-
- World Health Organization Leishmaniasis: Situation and Trends and Leishmaniasis Resources. 2015. http://www.who.int/neglected_diseases/diseases/en/http://www.who.int/gho/neglected_diseases/leishmaniasis/en/http://www.who.int/leishmaniasis/resources/AFGHANISTAN.pdf Available at. Accessed October 15, 2015.
-
- Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. Cutaneous leishmaniasis. Lancet Infect Dis. 2007;7:581–596. - PubMed
-
- Crogan J, Gunasekera H, Wood N, Sheikh M, Isaacs D. Management of Old World cutaneous leishmaniasis in refugee children. Pediatr Infect Dis J. 2010;29:357–359. - PubMed
-
- Sklavos AV, Walls T, Webber MT, Watson AB. Cutaneous leishmaniasis in a child treated with oral fluconazole. Australas J Dermatol. 2010;51:195–197. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources